Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionneuropeptide receptor activity

PROKR1 PROKR2 SORCS2 SORCS1

4.68e-0553754GO:0008188
GeneOntologyMolecularFunctiondATP binding

ST13P5 ST13

1.38e-045752GO:0032564
GeneOntologyMolecularFunctionpeptide receptor activity

PROKR1 PROKR2 GUCY2F SORCS2 SORCS1

1.84e-04140755GO:0001653
GeneOntologyMolecularFunctionadenyl deoxyribonucleotide binding

ST13P5 ST13

2.07e-046752GO:0032558
GeneOntologyMolecularFunctionpurine deoxyribonucleotide binding

ST13P5 ST13

2.89e-047752GO:0032554
GeneOntologyMolecularFunctiondeoxyribonucleotide binding

ST13P5 ST13

4.93e-049752GO:0032552
GeneOntologyMolecularFunctionneuropeptide Y receptor activity

PROKR1 PROKR2

7.49e-0411752GO:0004983
HumanPhenoAortopulmonary collateral arteries

SCN1A PLCB1 TBC1D24

1.95e-0515193HP:0031834
HumanPhenoFocal emotional seizure with laughing

SCN1A PLCB1 TBC1D24

2.90e-0517193HP:0010821
HumanPhenoFocal emotional seizure

SCN1A PLCB1 TBC1D24

3.47e-0518193HP:0025613
HumanPhenoFocal hemiclonic seizure

SCN1A PLCB1 TBC1D24

9.61e-0525193HP:0006813
DomainSp38

ZPBP ZPBP2

1.59e-052752PF07354
DomainSp38-bd

ZPBP ZPBP2

1.59e-052752IPR010857
DomainARM-type_fold

DOCK5 SMG1 NBEAL1 USP24 ASPM PSMD1 SERAC1 SPAG6

6.35e-05339758IPR016024
DomainVPS10

SORCS2 SORCS1

1.58e-045752SM00602
DomainSortilin_C

SORCS2 SORCS1

1.58e-045752PF15901
DomainSortilin-Vps10

SORCS2 SORCS1

1.58e-045752PF15902
DomainVPS10

SORCS2 SORCS1

1.58e-045752IPR006581
DomainSortilin_N

SORCS2 SORCS1

1.58e-045752IPR031778
DomainSortilin_C

SORCS2 SORCS1

1.58e-045752IPR031777
DomainPKD

SORCS2 SORCS1

3.30e-047752PF00801
DomainTPR-contain_dom

ZC3H7A FKBP6 VPS13A ST13P5 ST13

3.43e-04150755IPR013026
DomainTPR_REGION

ZC3H7A FKBP6 VPS13A ST13P5 ST13

5.31e-04165755PS50293
DomainTPR

ZC3H7A FKBP6 VPS13A ST13P5 ST13

5.31e-04165755PS50005
DomainPKD/Chitinase_dom

SORCS2 SORCS1

5.62e-049752IPR022409
DomainNPY_rcpt

PROKR1 PROKR2

5.62e-049752IPR000611
DomainPKD

SORCS2 SORCS1

5.62e-049752SM00089
DomainSialidases

SORCS2 SORCS1

5.62e-049752IPR011040
DomainSTI1

ST13P5 ST13

7.01e-0410752SM00727
DomainSTI1_HS-bd

ST13P5 ST13

7.01e-0410752IPR006636
DomainARM-like

SMG1 ASPM DOCK10 PSMD1 SERAC1 SPAG6

7.55e-04270756IPR011989
DomainIntegrin_alpha

ITGAL ITGAV

8.55e-0411752PF00357
DomainPKD

SORCS2 SORCS1

8.55e-0411752PS50093
DomainPKD_dom

SORCS2 SORCS1

8.55e-0411752IPR000601
DomainDOCK_C

DOCK5 DOCK10

8.55e-0411752IPR010703
DomainDHR-1_domain

DOCK5 DOCK10

8.55e-0411752IPR027007
DomainDHR_2

DOCK5 DOCK10

8.55e-0411752PS51651
DomainDHR_1

DOCK5 DOCK10

8.55e-0411752PS51650
DomainDOCK-C2

DOCK5 DOCK10

8.55e-0411752PF14429
DomainDHR-2

DOCK5 DOCK10

8.55e-0411752IPR027357
DomainDHR-2

DOCK5 DOCK10

8.55e-0411752PF06920
DomainDOCK

DOCK5 DOCK10

8.55e-0411752IPR026791
Domain-

SORCS2 SORCS1

8.55e-04117522.60.40.670
DomainIntegrin_alpha_C_CS

ITGAL ITGAV

1.84e-0316752IPR018184
DomainIntegrin_alpha-2

ITGAL ITGAV

2.34e-0318752IPR013649
DomainIntegrin_alpha2

ITGAL ITGAV

2.34e-0318752PF08441
DomainIntegrin_alpha

ITGAL ITGAV

2.34e-0318752IPR000413
DomainINTEGRIN_ALPHA

ITGAL ITGAV

2.34e-0318752PS00242
DomainTPR-like_helical_dom

ZC3H7A FKBP6 IFT122 ST13P5 ST13

2.46e-03233755IPR011990
DomainInt_alpha_beta-p

ITGAL ITGAV

2.60e-0319752IPR013519
DomainInt_alpha

ITGAL ITGAV

2.60e-0319752SM00191
DomainRNaseH-like_dom

REXO5 PIWIL3 ZBED5

2.69e-0369753IPR012337
DomainTIR

TLR3 TLR7

3.18e-0321752SM00255
DomainFG_GAP

ITGAL ITGAV

3.49e-0322752PS51470
DomainTIR

TLR3 TLR7

3.49e-0322752PF01582
Domain-

TLR3 TLR7

3.81e-03237523.40.50.10140
DomainFG-GAP

ITGAL ITGAV

4.15e-0324752PF01839
DomainFG-GAP

ITGAL ITGAV

4.15e-0324752IPR013517
DomainTIR

TLR3 TLR7

4.15e-0324752PS50104
DomainIQ

SCN1A ASPM LRRIQ4

4.24e-0381753SM00015
DomainIntegrin_dom

ITGAL ITGAV

4.50e-0325752IPR032695
DomainTIR_dom

TLR3 TLR7

4.50e-0325752IPR000157
DomainIQ_motif_EF-hand-BS

SCN1A ASPM LRRIQ4

5.69e-0390753IPR000048
DomainIQ

SCN1A ASPM LRRIQ4

6.23e-0393753PS50096
DomainAbhydrolase_1

ABHD16B LIPM

6.86e-0331752PF00561
DomainLRRCT

TLR3 TLR7

7.30e-0332752PF01463
DomainAB_hydrolase_1

ABHD16B LIPM

7.75e-0333752IPR000073
Pubmed

Lack of pathogenic mutations in six patients with MMPSI.

SCN1A PLCB1 TBC1D24

4.00e-08476324315024
Pubmed

Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human gammadelta T cells.

TLR3 TLR7

4.71e-06276219887600
Pubmed

Plasmacytoid dendritic cells regulate colitis-associated tumorigenesis by controlling myeloid-derived suppressor cell infiltration.

TLR3 TLR7

4.71e-06276232810576
Pubmed

Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists.

TLR3 TLR7

4.71e-06276226255864
Pubmed

Expression of prokineticin receptors in mouse cultured astrocytes and involvement in cell proliferation.

PROKR1 PROKR2

4.71e-06276216901473
Pubmed

TLR3\TLR7 as Differentially Expressed Markers Among Viral, Nonviral, and Autoimmune Diseases in Egyptian Patients.

TLR3 TLR7

4.71e-06276234342515
Pubmed

U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7.

TLR3 TLR7

4.71e-06276216368889
Pubmed

Extracellular RNA Sensing Mediates Inflammation and Organ Injury in a Murine Model of Polytrauma.

TLR3 TLR7

4.71e-06276237133342
Pubmed

Upregulation of TLR7 and TLR3 gene expression in the lung of respiratory syncytial virus infected mice.

TLR3 TLR7

4.71e-06276219445181
Pubmed

Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor.

PROKR1 PROKR2

4.71e-06276211886876
Pubmed

Skewed endosomal RNA responses from TLR7 to TLR3 in RNase T2-deficient macrophages.

TLR3 TLR7

4.71e-06276234161582
Pubmed

RNA receptors, TLR3 and TLR7, are potentially associated with SLE clinical features.

TLR3 TLR7

4.71e-06276233650302
Pubmed

Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines.

TLR3 TLR7

4.71e-06276220309865
Pubmed

Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands.

TLR3 TLR7

4.71e-06276223019335
Pubmed

Prognostic impact of toll-like receptors gene polymorphism on outcome of COVID-19 pneumonia: A case-control study.

TLR3 TLR7

4.71e-06276235063671
Pubmed

Dysregulation of Toll-Like Receptor 7 Compromises Innate and Adaptive T Cell Responses and Host Resistance to an Attenuated West Nile Virus Infection in Old Mice.

TLR3 TLR7

4.71e-06276226581984
Pubmed

Differential effects of toll-like receptor stimulation on mRNA-driven myogenic conversion of human and mouse fibroblasts.

TLR3 TLR7

4.71e-06276227586271
Pubmed

Association between polymorphisms of prokineticin receptor (PKR1 rs4627609 and PKR2 rs6053283) and recurrent pregnancy loss.

PROKR1 PROKR2

4.71e-06276226984842
Pubmed

Synergy of TLR3 and 7 ligands significantly enhances function of DCs to present inactivated PRRSV antigen through TRIF/MyD88-NF-κB signaling pathway.

TLR3 TLR7

4.71e-06276227046485
Pubmed

TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements.

TLR3 TLR7

4.71e-06276216105838
Pubmed

Loss of zona pellucida binding proteins in the acrosomal matrix disrupts acrosome biogenesis and sperm morphogenesis.

ZPBP ZPBP2

4.71e-06276217664285
Pubmed

Toll-Like Receptor 7 Enhances Rabies Virus-Induced Humoral Immunity by Facilitating the Formation of Germinal Centers.

TLR3 TLR7

4.71e-06276230906301
Pubmed

Modeling of human prokineticin receptors: interactions with novel small-molecule binders and potential off-target drugs.

PROKR1 PROKR2

4.71e-06276222132188
Pubmed

Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo.

TLR3 TLR7

4.71e-06276216537810
Pubmed

Association of TLR3 gene 1377C/T (rs3775290) and TLR7 gene C/G (rs3853839) polymorphism with hand, foot, and mouth disease caused by human enterovirus 71 infection susceptibility and severity in the Chinese Han population: A meta-analysis of case-control studies.

TLR3 TLR7

4.71e-06276235801751
Pubmed

Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3.

TLR3 TLR7

4.71e-06276225539593
Pubmed

Enteric Viruses Ameliorate Gut Inflammation via Toll-like Receptor 3 and Toll-like Receptor 7-Mediated Interferon-β Production.

TLR3 TLR7

4.71e-06276227084119
Pubmed

Prokineticin receptor variants (PKR1-I379V and PKR2-V331M) are protective genotypes in human early pregnancy.

PROKR1 PROKR2

4.71e-06276223687280
Pubmed

St13 protects against disordered acinar cell arachidonic acid pathway in chronic pancreatitis.

ST13P5 ST13

4.71e-06276235562743
Pubmed

Toll-like receptor 3 and 7/8 function is impaired in hepatitis C rapid fibrosis progression post-liver transplantation.

TLR3 TLR7

1.41e-05376223425350
Pubmed

Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.

TLR3 TLR7

1.41e-05376217981792
Pubmed

The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain.

PROKR1 PROKR2

1.41e-05376219667192
Pubmed

Genetic variations in Toll-like receptors (TLRs 3/7/8) are associated with systemic lupus erythematosus in a Taiwanese population.

TLR3 TLR7

1.41e-05376224445780
Pubmed

Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

TLR3 TLR7

1.41e-05376224692849
Pubmed

Toll-like receptor polymorphisms and age-related macular degeneration.

TLR3 TLR7

1.41e-05376218385087
Pubmed

Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth.

TLR3 TLR7

1.41e-05376228300057
Pubmed

TLR3 deficiency impairs spinal cord synaptic transmission, central sensitization, and pruritus in mice.

TLR3 TLR7

1.41e-05376222565312
Pubmed

Cryo-EM structures of Toll-like receptors in complex with UNC93B1.

TLR3 TLR7

1.41e-05376233432245
Pubmed

Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.

TLR3 TLR7

1.41e-05376230321082
Pubmed

Modulation of TLR 3, 7 and 8 expressions in HCV genotype 3 infected individuals: potential correlations of pathogenesis and spontaneous clearance.

TLR3 TLR7

1.41e-05376225126563
Pubmed

Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation.

PROKR1 PROKR2

1.41e-05376217531315
Pubmed

TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells.

TLR3 TLR7

1.41e-05376215210814
Pubmed

Expression of IL-27 p28 by Theiler's virus-infected macrophages depends on TLR3 and TLR7 activation of JNK-MAP-kinases.

TLR3 TLR7

1.41e-05376217675254
Pubmed

Genetically defined variants of toll-like receptors 3, 7 and 9 as phenotype and risk modifier factors for psoriasis.

TLR3 TLR7

1.41e-05376229290528
Pubmed

Synergy of TRIF-dependent TLR3 and MyD88-dependent TLR7 in up-regulating expression of mouse FPR2, a promiscuous G-protein-coupled receptor, in microglial cells.

TLR3 TLR7

1.41e-05376219559490
Pubmed

Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptors.

PROKR1 PROKR2

1.41e-05376222138749
Pubmed

The three sorCS genes are differentially expressed and regulated by synaptic activity.

SORCS2 SORCS1

1.41e-05376215009648
Pubmed

Antagonism of the Prokineticin System Prevents and Reverses Allodynia and Inflammation in a Mouse Model of Diabetes.

PROKR1 PROKR2

1.41e-05376226730729
Pubmed

Vitamin D3 Alters the Expression of Toll-like Receptors in Peripheral Blood Mononuclear Cells of Patients With Systemic Lupus Erythematosus.

TLR3 TLR7

1.41e-05376228544067
Pubmed

Hepatitis C virus infection decreases the expression of Toll-like receptors 3 and 7 via upregulation of miR-758.

TLR3 TLR7

1.41e-05376225008898
Pubmed

Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gamma.

TLR3 TLR7

1.41e-05376215634897
Pubmed

Respiratory macrophages and dendritic cells mediate respiratory syncytial virus-induced IL-33 production in TLR3- or TLR7-dependent manner.

TLR3 TLR7

1.41e-05376226603638
Pubmed

Hidden Twins: SorCS Neuroreceptors Form Stable Dimers.

SORCS2 SORCS1

1.41e-05376228827148
Pubmed

Cervical cancer cell supernatants induce a phenotypic switch from U937-derived macrophage-activated M1 state into M2-like suppressor phenotype with change in Toll-like receptor profile.

TLR3 TLR7

1.41e-05376225309919
Pubmed

Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration.

PROKR1 PROKR2

1.41e-05376220023120
Pubmed

The association of single nucleotide polymorphisms of Toll-like receptor 3, Toll-like receptor 7 and Toll-like receptor 8 genes with the susceptibility to HCV infection.

TLR3 TLR7

1.41e-05376229947302
Pubmed

Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.

TLR3 TLR7

1.41e-05376216111635
Pubmed

Polymorphisms of endocrine gland-derived vascular endothelial growth factor gene and its receptor genes are associated with recurrent pregnancy loss.

PROKR1 PROKR2

1.41e-05376220847187
Pubmed

B Cell-intrinsic TLR7 signaling is required for optimal B cell responses during chronic viral infection.

TLR3 TLR7

1.41e-05376223761632
Pubmed

In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C.

TLR3 TLR7

1.41e-05376223489702
Pubmed

Toll-like receptors 3, 7, and 9 in Juvenile nasopharyngeal angiofibroma.

TLR3 TLR7

1.41e-05376225912131
Pubmed

Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses.

TLR3 TLR7

1.41e-05376216935934
Pubmed

Prokineticin receptors interact unselectively with several G protein subtypes but bind selectively to β-arrestin 2.

PROKR1 PROKR2

1.41e-05376233811988
Pubmed

Differential expression of viral PAMP receptors mRNA in peripheral blood of patients with chronic hepatitis C infection.

TLR3 TLR7

1.41e-05376218021446
Pubmed

Contribution of Toll like receptor polymorphisms to dengue susceptibility and clinical outcome among eastern Indian patients.

TLR3 TLR7

1.41e-05376231481269
Pubmed

Innate immune memory and homeostasis may be conferred through crosstalk between the TLR3 and TLR7 pathways.

TLR3 TLR7

1.41e-05376227405980
Pubmed

Characterization of TLR-induced inflammatory responses in COPD and control lung tissue explants.

TLR3 TLR7

1.41e-05376227729782
Pubmed

MAVS mediates a protective immune response in the brain to Rift Valley fever virus.

TLR3 TLR7

1.41e-05376235584192
Pubmed

The Chaperone UNC93B1 Regulates Toll-like Receptor Stability Independently of Endosomal TLR Transport.

TLR3 TLR7

1.41e-05376229768176
Pubmed

Spatiotemporal expression analysis of the growth factor receptor SorCS3.

SORCS2 SORCS1

1.41e-05376224715575
Pubmed

Gene-gene interactions and risk of recurrent miscarriages in carriers of endocrine gland-derived vascular endothelial growth factor and prokineticin receptor polymorphisms.

PROKR1 PROKR2

1.41e-05376225064403
Pubmed

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.

TLR3 TLR7

1.41e-05376237020259
Pubmed

Transcriptomic Analysis and C-Terminal Epitope Tagging Reveal Differential Processing and Signaling of Endogenous TLR3 and TLR7.

TLR3 TLR7

1.41e-05376234211474
Pubmed

Expression and regulation of the prokineticins (endocrine gland-derived vascular endothelial growth factor and Bv8) and their receptors in the human endometrium across the menstrual cycle.

PROKR1 PROKR2

2.82e-05476215126578
Pubmed

The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells.

PROKR1 PROKR2

2.82e-05476212604792
Pubmed

The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling.

TLR3 TLR7

2.82e-05476217452530
Pubmed

Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing.

TLR3 TLR7

2.82e-05476219451267
Pubmed

TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes.

TLR3 TLR7

2.82e-05476221844166
Pubmed

Identification and characterization of human ZPBP-like gene in silico.

ZPBP ZPBP2

2.82e-05476212883658
Pubmed

Painful pathways induced by TLR stimulation of dorsal root ganglion neurons.

TLR3 TLR7

2.82e-05476221515789
Pubmed

Abnormal Pain Sensation in Mice Lacking the Prokineticin Receptor PKR2: Interaction of PKR2 with Transient Receptor Potential TRPV1 and TRPA1.

PROKR1 PROKR2

2.82e-05476231883821
Pubmed

Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon.

TLR3 TLR7

2.82e-05476216985170
Pubmed

Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design.

TLR3 TLR7

2.82e-05476228416600
Pubmed

Expression of TLR3, 4, 7 and 9 in cutaneous malignant melanoma: relationship with clinicopathological characteristics and prognosis.

TLR3 TLR7

2.82e-05476223179584
Pubmed

Extracellular MicroRNAs Induce Potent Innate Immune Responses via TLR7/MyD88-Dependent Mechanisms.

TLR3 TLR7

2.82e-05476228768728
Pubmed

The genes for the human VPS10 domain-containing receptors are large and contain many small exons.

SORCS2 SORCS1

2.82e-05476211499680
Pubmed

Endosomal TLR3, TLR7, and TLR8 control neuronal morphology through different transcriptional programs.

TLR3 TLR7

2.82e-05476229777026
Pubmed

The Src-ZNRF1 axis controls TLR3 trafficking and interferon responses to limit lung barrier damage.

TLR3 TLR7

2.82e-05476237158982
Pubmed

Prokineticins in central and peripheral control of human reproduction.

PROKR1 PROKR2

2.82e-05476226574895
Pubmed

Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma.

TLR3 TLR7

2.82e-05476221990957
Pubmed

TLR7 mediated viral recognition results in focal type I interferon secretion by dendritic cells.

TLR7 ITGAL

2.82e-05476229150602
Pubmed

Association of Genetic Polymorphisms in TLR3, TLR4, TLR7, and TLR8 with the Clinical Forms of Dengue in Patients from Veracruz, Mexico.

TLR3 TLR7

2.82e-05476233138336
Pubmed

Cardiac RNA induces inflammatory responses in cardiomyocytes and immune cells via Toll-like receptor 7 signaling.

TLR3 TLR7

2.82e-05476226363072
Pubmed

LFA-1 and CD2 synergize for the Erk1/2 activation in the Natural Killer (NK) cell immunological synapse.

CD2 ITGAL

2.82e-05476219502238
Pubmed

Prokineticin Ligands and Receptors Are Expressed in the Human Fetal Ovary and Regulate Germ Cell Expression of COX2.

PROKR1 PROKR2

2.82e-05476226192875
Pubmed

Recognition of pathogen-associated nucleic acids by endosomal nucleic acid-sensing toll-like receptors.

TLR3 TLR7

2.82e-05476223369718
Pubmed

Molecular cloning and characterization of prokineticin receptors.

PROKR1 PROKR2

2.82e-05476212427552
Pubmed

The adjuvant effect of TLR agonists on CD4(+) effector T cells is under the indirect control of regulatory T cells.

TLR3 TLR7

2.82e-05476221538349
Pubmed

Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases.

TLR3 TLR7

2.82e-05476220451253
Pubmed

The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy.

PROKR1 PROKR2

2.82e-05476216763065
GeneFamilyProkineticin receptors

PROKR1 PROKR2

8.76e-062542216
GeneFamilyADAM metallopeptidase domain containing|CD molecules

CD2 CD6 TLR3 SIGLEC5 CCR4 ITGAL ITGAV

1.62e-04394547471
GeneFamilyCD molecules|Toll like receptors

TLR3 TLR7

3.88e-0410542948
GeneFamilyCD molecules|Integrin alpha subunits

ITGAL ITGAV

1.30e-03185421160
ToppCellControl-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations)

CD2 CD6 RABGAP1L DOCK10 PLCB1 CRYBG1 ITGAL

2.78e-0818575702ab64c0166c0646d1d4c6ed110ef0b75a1096d0
ToppCellCOVID-19-kidney-T-cells-2|COVID-19 / Disease (COVID-19 only), tissue and cell type

CD2 CD6 ASPM DOCK10 CCR4 ITGAL MCOLN2

3.10e-0818875715484c05cb496cd98ed3f79a6134c5cec8f09a4d
ToppCellCOVID-19-kidney-T-cells-2|kidney / Disease (COVID-19 only), tissue and cell type

CD2 CD6 ASPM DOCK10 CCR4 ITGAL MCOLN2

3.46e-08191757698e6a28276704f8baa082d028db2345b973c4bc
ToppCellControl-T_cells|Control / group, cell type (main and fine annotations)

CD2 CD6 RABGAP1L DOCK10 CRYBG1 ITGAL

7.55e-07187756f4e8e0eba58da89b56587667555a5d4754e108c7
ToppCellCOVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations)

CD2 CD6 RABGAP1L DOCK10 ITGAL MCOLN2

8.03e-071897562c018d6120f65f0b2704b483bc9da1c0984872e3
ToppCelldroplet-Thymus-nan-18m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2 CD6 CCR4 ITGAL PTGIR ST13

8.28e-071907568f5e71a0861ee4e8f3ce45e8a7f18fb9d6036a3c
ToppCellCOVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations)

CD2 CD6 RABGAP1L DOCK10 ITGAL MCOLN2

8.54e-071917567f64add931b64b8d35836fa6bee9ebab593844d3
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD2 CD6 PTPRE ITGAL MCOLN2 WDR47

9.93e-07196756c100967851f037b3522130a9e2a4175ad593ecbc
ToppCellTracheal-10x5prime-Immune_Lymphocytic-T-T_CD4-T_reg|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 ASPM CCR4 ITGAL MCOLN2

9.93e-07196756c0028307cf5dddfc4b5db1445fa83b74019a20bd
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 DOCK10 CCR4 ITGAL MCOLN2

1.12e-062007567a9c3f51d4a8fda5f1b7e0be6fcf9c1c92fffe99
ToppCell356C-Lymphocytic-CD4_T-cell-Treg_cell_4|356C / Donor, Lineage, Cell class and subclass (all cells)

ZC3H7A CD2 CD6 CCR4 PTGIR

6.07e-06153755cda759ab83a271974651fe4faa21ed4f7ecbb3ae
ToppCellFetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

PTPRE P2RY6 TLR3 ITGAL MCOLN2

6.46e-061557559f937ae48767fdcf1a944af4de0530d9c0ab441d
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD2 CD6 POLE2 DOCK10 MCOLN2

6.67e-06156755fbe23876f0899853cea3c5c4f3044a9cea064d5b
ToppCellPND07-28-samps|World / Age Group, Lineage, Cell class and subclass

CD2 PTPRE DOCK10 SIGLEC5 ITGAL

6.88e-06157755a2005768a6d268879e3fd6dbd8cf674dc98be587
ToppCell356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SMG1 OLFML2A FMO2 TLR7 MCOLN2

7.54e-061607550293b244c063a62819690bf22bbc2681f8d15252
ToppCell356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SMG1 OLFML2A FMO2 TLR7 MCOLN2

7.54e-061607553eaae86fa08f7651021316f8e5811bf48055591e
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CD2 CD6 LIPM DOCK10 ITGAL

8.76e-061657558dbd03795fff060cd2e4d5d97348f5b63515e030
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CD2 CD6 LIPM DOCK10 ITGAL

8.76e-061657555fc5e34cc805df44c020256729256ef761790152
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CD2 CD6 LIPM DOCK10 ITGAL

8.76e-0616575564c7c45383afde1d050934938705e47aa615755f
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD2 CD6 VPS13A DOCK10 CRYBG1

9.28e-0616775583969c36ac44b96afc9aa09400a99fa2b487f7ff
ToppCellfacs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2 CD6 DOCK10 TLR7 FAM174C

9.56e-06168755182f08106ac65ea501e2fb9139d3b44b7c4662c9
ToppCellTCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9

PTPRE RABGAP1L PWWP3A IFT122 ITGAV

9.56e-06168755c70bf73bb800e4722cedc35bbc17ea3113d1012d
ToppCellPND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CD2 CD6 ZPBP ASPM ZPBP2

1.01e-051707552d5e56eee0c3ce75a9641cc14dee0e0807141c32
ToppCelldroplet-Kidney-KIDNEY-1m-Lymphocytic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2 ZPBP SORCS2 ITGAL PTGIR

1.10e-05173755de124fb7ded04664d4184bf12f1f201c0784f07c
ToppCellfacs-Heart-RV-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2 CD6 SCN1A ALS2 CCR4

1.20e-051767553e7647364c13beade9ca278c7ce8e89546e0b060
ToppCellfacs-Heart-RV-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2 CD6 SCN1A ALS2 CCR4

1.20e-05176755a55572470de6af6cbf29ed4f785fdca62d24cd23
ToppCellDendritic_Cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id

P2RY6 DOCK10 CLLU1 PTGIR MCOLN2

1.23e-05177755d2cd081bdda0eba9f6f6473c4d3939e4bee3440e
ToppCellfacs-Skin-Anagen-3m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2 CD6 DOCK10 MTCL1 ITGAL

1.23e-051777557853430fb0d1a18d835e8956777e0616c5d7d412
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2 CD6 DOCK10 CCR4 ITGAL

1.23e-051777559d2d70d53b919fed3328812889a55e5e1a0759de
ToppCellfacs-Skin-Anagen-3m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2 CD6 DOCK10 MTCL1 ITGAL

1.23e-05177755395f005f019aabb18738d3a10a04c37f216deda3
ToppCellfacs-Skin-Anagen-3m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2 CD6 DOCK10 MTCL1 ITGAL

1.23e-051777559a5bf67a801826d094f679dd2189b62296c9694f
ToppCelldroplet-Tongue-nan-24m-Myeloid-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2 CD6 DOCK10 CCR4 ITGAL

1.26e-051787559423e209de94d26e96117581c95dc069850225d3
ToppCellPCW_13-14-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

PTPRE P2RY6 CRYBG1 ITGAL MCOLN2

1.30e-051797559fc44637c9a7551fd47b8533e45a9c199e164a95
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD2 CD6 P2RY6 LYG2 ITGAL

1.37e-051817555cecbafc29cc95896e6ccb2c74d9237b9aaece69
ToppCelldroplet-Thymus-nan-3m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2 CD6 CCR4 PTGIR ST13

1.56e-0518675511929e36d8c9b4c4bc2f5e912f139f474f91ab00
ToppCellLPS-antiTNF-Myeloid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK5 PTPRE SIGLEC5 ITGAL TBC1D24

1.56e-05186755839c6da5244f469461b2e5563e36162b2911cd01
ToppCellhuman_hepatoblastoma-NK.T_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

CD2 CD6 DOCK10 CRYBG1 ITGAL

1.64e-0518875571b7599e7e1d63cc0c8518c0501533755951d58f
ToppCellControl-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations)

CD2 CD6 DOCK10 CRYBG1 ITGAL

1.73e-051907550733be5e54fe15d6d6ea51c154a95258e83f1b92
ToppCelldroplet-Thymus-nan-18m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2 CD6 CCR4 PTGIR ST13

1.73e-0519075584265be128170cbb08d76e824aa108e07da9c3e5
ToppCellCOVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type

CD2 CD6 DOCK10 ITGAL MCOLN2

1.73e-05190755e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf
ToppCellNS-control-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD2 CD6 DOCK10 ITGAL MCOLN2

1.77e-0519175527f2151da2f41015a979499f274ab1284a36189f
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CD2 CD6 DOCK10 ITGAL MCOLN2

1.77e-05191755d9506b88d806aadd4c2b9bf86fe994c47799e7f6
ToppCellcontrol-Lymphoid-CTL|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CD2 CD6 DOCK10 ITGAL MCOLN2

1.77e-051917558df23473e24cfa51c09986102ddd391ed0f0b9cc
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CD2 CD6 DOCK10 ITGAL MCOLN2

1.77e-05191755b42c54308abe1241cc38ddce96b9d38d07983891
ToppCellCOVID-19-lung-CD8+_T_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type

CD2 CD6 DOCK10 ITGAL MCOLN2

1.77e-05191755543f8ae07cc2e6950c888115a5ca9445e3c0f618
ToppCellCOVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations)

CD2 CD6 RABGAP1L DOCK10 ITGAL

1.77e-051917550646cca78e24aeb6baa9934d3c439b797c567997
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CD2 CD6 DOCK10 ITGAL MCOLN2

1.77e-051917559aabbc65430e2233b8f2d3fff9face7807b88b48
ToppCellNS-critical-d_07-13-Lymphoid-Treg|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD2 CD6 DOCK10 CCR4 ITGAL

1.82e-05192755cd34defac6565d34db507918e791b09c79f7d1f8
ToppCellNS-control-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD2 CD6 DOCK10 CCR4 ITGAL

1.82e-05192755ef252dd9df161f665f53c047c0514381f80d6683
ToppCellcontrol-Lymphoid-Treg|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CD2 CD6 DOCK10 CCR4 ITGAL

1.82e-051927559067e90b7c2d734100d6e5026d753113bf9428a3
ToppCell10x3'2.3-week_14-16-Myeloid_DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

CD2 PTPRE P2RY6 TLR7 MCOLN2

1.87e-05193755c6633aca0eb4d699c4d3da3199b84bebd87e2d31
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TLR3 USP24 DOCK10 TLR7 ITGAV

1.87e-0519375506b65110db974f4ef90d3511ff34428976a52c9c
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TLR3 USP24 DOCK10 TLR7 ITGAV

1.87e-051937559c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCellfacs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TLR3 USP24 DOCK10 TLR7 ITGAV

1.87e-05193755a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCellsevere-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SMG1 USP24 VPS13A OCLN MCOLN2

1.87e-051937559337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCellAdult-Immune-T_lymphocyte|Adult / Lineage, Cell type, age group and donor

CD2 CD6 DOCK10 PLCB1 ITGAL

1.87e-0519375526df0c4c8a2355dd5503fadd07e368eb9a2bf06a
ToppCellCOVID-19-kidney-T-cells-1|COVID-19 / Disease (COVID-19 only), tissue and cell type

CD2 CD6 DOCK10 ITGAL MCOLN2

1.87e-051937555b84fa640cf30dea55fde53b810f850ff946d253
ToppCell10x3'2.3-week_14-16-Myeloid_DC-DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

CD2 PTPRE P2RY6 TLR7 MCOLN2

1.87e-05193755a32791b4bdb7c5f2b4cc75b660321ab75c4fac9b
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TLR3 USP24 DOCK10 TLR7 ITGAV

1.87e-05193755b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCell5'-Adult-LargeIntestine-Hematopoietic-T_cells-CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CD2 CD6 DOCK10 CCR4 ITGAL

1.91e-051947559344556b375fd9267652cdca57b2cbd50a878a1e
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CD2 CD6 DOCK10 ITGAL MCOLN2

1.91e-051947554dfc890bacf133cfb6ec7c8b73f084f2491cf78e
ToppCellhuman_hepatoblastoma-NK.T_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)

CD2 CD6 DOCK10 CRYBG1 ITGAL

1.91e-05194755997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6
ToppCellAdult-Immune-T_lymphocyte-D231|Adult / Lineage, Cell type, age group and donor

CD2 CD6 DOCK10 PLCB1 ITGAL

1.91e-051947555c1dca33f382f37a7deb23e573578343c3b54986
ToppCelldistal-Hematologic-Myeloid_Dendritic_Type_2-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

DOCK5 PTPRE P2RY6 CCR4 MCOLN2

1.96e-051957557606b8b40e704bb5447ac57ccf8698794e9c7890
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD2 CD6 DOCK10 ITGAL MCOLN2

1.96e-0519575531b011f3d54e6729802aad1f771cef77744e3ff2
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CD2 CD6 PTPRE DOCK10 ITGAL

1.96e-051957552d485373bfd9bb4bb9236bf0b31d03e132c8018f
ToppCellCOVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type

CD2 CD6 ASPM DOCK10 ITGAL

1.96e-051957557e05e56f8d0a7a052830c7db12b10dace7d10760
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD2 CD6 DOCK10 CRYBG1 ITGAL

2.01e-05196755e4c76e7ad68455e51fe93ce588bcec9383f8654b
ToppCellIPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class

CD2 CD6 DOCK10 CRYBG1 CCR4

2.01e-051967556e70c48a63d9673eb16b0847c1bd88eecc2f7a3c
ToppCellcontrol-Lymphoid|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CD2 CD6 DOCK10 ITGAL MCOLN2

2.01e-051967558ed172bb3a95f09722476f0880ae246561777d98
ToppCellCOPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class

CD2 CD6 DOCK10 CRYBG1 CCR4

2.01e-05196755c9bdd505c3ab380ed7b272aa518df31a0a706a06
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CD2 CD6 PTPRE DOCK10 ITGAL

2.06e-051977550523aec9713ae21e6b879aa98e07fa2576610d5f
ToppCellCOVID-19-kidney-T-cells-1|kidney / Disease (COVID-19 only), tissue and cell type

CD2 CD6 DOCK10 ITGAL MCOLN2

2.06e-051977559bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e
ToppCellTracheal-10x5prime-Immune_Lymphocytic-T-T_CD4|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 DOCK10 CCR4 ITGAL

2.11e-0519875512cd44bc02c7577fbcf230957a1fecc1e5bfde37
ToppCellTracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 DOCK10 CCR4 ITGAL

2.16e-0519975509e0b45529fa9d5fc86da1747b3fb3a238a09aa6
ToppCellTracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 ASPM DOCK10 ITGAL

2.16e-05199755868ff080f72b6274a84e3ae0ddee4a32ed96472a
ToppCellTracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 DOCK10 CCR4 ITGAL

2.16e-051997556150b272313d3fbf5ddcb3a8d51862d368220fe2
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 DOCK10 PLCB1 ITGAL

2.16e-05199755fbdde57dd88656621801e65ee2818251588f3874
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 DOCK10 CCR4 ITGAL

2.16e-051997553f4907fa6d81c5691c19e6798145e9f9eccdfd20
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 DOCK10 PLCB1 ITGAL

2.21e-05200755be9a43acc2f926b9433ab3f018b911b03896a924
ToppCellTracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 DOCK10 CCR4 ITGAL

2.21e-0520075568589705dbc84482b6c0a1a27dd552492c4e8c3d
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 DOCK10 PLCB1 ITGAL

2.21e-052007556b34f2b85d4f83c1270ee151f602cba6f42042ba
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 DOCK10 PLCB1 ITGAL

2.21e-05200755c6c2b39359c65c9444987d02d1c899dff2ad1366
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 DOCK10 PLCB1 ITGAL

2.21e-0520075566fb892bda1d29e67a65717e85f2ec221f520b2a
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 DOCK10 PLCB1 ITGAL

2.21e-0520075502c4169a23e5aaa0d4bfc78b51ba19ce8157dc3e
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 DOCK10 PLCB1 ITGAL

2.21e-05200755b2c5618aa1ac19423996336795dadb39ea57cda7
ToppCellTracheal-NucSeq-Immune_Myeloid-Dendritic_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PTPRE P2RY6 DOCK10 SIGLEC5 MCOLN2

2.21e-0520075541a206350eff2a196ccc1a36a9636a87c74f6962
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 DOCK10 CCR4 ITGAL

2.21e-05200755f7a9d8b99de19e9842422bada348d940e0863645
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 DOCK10 ITGAL MCOLN2

2.21e-05200755510d84bf7a4621b079e5a7330d25e04508c84a49
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CD2 CD6 DOCK10 PLCB1 ITGAL

2.21e-052007559ef322486e46e4ff05a8cbe06cf8019e996c94b3
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT3 PTGIR MCOLN2 SORCS1

5.92e-05125754b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b
ToppCellfacs-Aorta-Heart-3m-Mesenchymal-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

P2RY6 DOCK10 LRRIQ4 MCOLN2

8.46e-05137754587a369b148bb2600c06db39298feddfc99cb6ad
ToppCellfacs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC9C1 GUCY2F SCN1A PKHD1

1.05e-0414575496712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TLR3 TLR7 ITGAL WDPCP

1.05e-041457549743d68ba8bfef56fd9a979ab357c0e287eb5ae2
ToppCellmetastatic_Lymph_Node-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass

CD2 CD6 ZPBP USP24

1.14e-04148754db046a02a00829910bf9d7dbda068e730aa78f00
ToppCellLPS-IL1RA-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TLR7 ITGAL PTGIR PIWIL3

1.17e-04149754a464c0fd54e3c9e1d40d95b49489cb9371dd7c24
ToppCelldroplet-Kidney-nan-24m-Lymphocytic-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

REXO5 PTPRE TLR7 ITGAL

1.20e-0415075434774b015adecc2be56a471fda8994e89a6ad93e
ToppCelldroplet-Lung-nan-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

P2RY6 DOCK10 SIGLEC5 ITGAL

1.23e-04151754c743dc8758416a4f562d60c8fd2df7e659ab6951
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD2 CD6 P2RY6 ITGAL

1.26e-041527545adcdf93fd3ca066402aaaf308c363e4648f871d
ToppCellControl-Myeloid-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK5 PTPRE SIGLEC5 ITGAL

1.30e-04153754c33d63b2d1a220bc428e776b157b23faa43ea8ca
DiseaseEpilepsy, Myoclonic, Infantile

SCN1A TBC1D24

2.76e-0410742C0917800
Diseasevisual epilepsy (is_implicated_in)

ASPM TBC1D24

3.36e-0411742DOID:11832 (is_implicated_in)
Diseaseperinatal necrotizing enterocolitis (biomarker_via_orthology)

TLR3 TLR7

8.24e-0417742DOID:8677 (biomarker_via_orthology)
DiseasePrimary microcephaly

TUBGCP6 ASPM

1.39e-0322742C0431350
Diseasespermatogenic failure (is_implicated_in)

FKBP6 ZPBP

1.52e-0323742DOID:0111910 (is_implicated_in)
Diseaseanogenital venereal wart (is_marker_for)

TLR3 TLR7

1.94e-0326742DOID:11168 (is_marker_for)
Diseasecortex volume change measurement, age at assessment

SORCS2 TOP1

2.25e-0328742EFO_0008007, EFO_0021500
DiseaseHematopoetic Myelodysplasia

EPO PLCB1

2.41e-0329742C2713368

Protein segments in the cluster

PeptideGeneStartEntry
KSYLKRIFQLVRFLF

ALS2

1416

Q96Q42
FVALLVFYITKRKKQ

CD2

226

P06729
RFVYNSERKKFLPLL

POLE2

96

P56282
FLGEKFRKYILQLFK

CCR4

306

P51679
RKQFLLYRKAAVVLQ

ASPM

2876

Q8IZT6
AVRIQRAYKLYLAVK

ASPM

3121

Q8IZT6
FVKALVRVFKIYLTA

ABHD16B

6

Q9H3Z7
RLAILYAKRASVFVK

ST13P5

146

Q8NFI4
RLAILYAKRASVFVK

ST13

146

P50502
FRKKYGVQFLLDTLR

NBEAL1

1036

Q6ZS30
IKEAARFKRRVLIQY

INTS6L

821

Q5JSJ4
RSLKQNIFLFYVKLR

MTCL1

1031

Q9Y4B5
AFALIIFFAVKTRRK

OCLN

256

Q16625
LIFIAFILLRIKGKY

CD6

416

P30203
VLLLAAYFFRFRKQR

PTPRE

61

P23469
TAKKAFIRVQDLRYL

IFT122

661

Q9HBG6
GKKEFLYQTRFLRQL

LIPM

241

Q5VYY2
KLREIYLKRNQFEVF

LRRIQ4

166

A6NIV6
LYFLIRAFRLKKPQR

FAM174C

86

Q9BVV8
ARYIFKRLKFLGNKE

LPCAT3

346

Q6P1A2
FLFKKLGRQLRYLAE

TUBGCP6

461

Q96RT7
ALKFFRVQLPKRYRA

RABGAP1L

751

Q5R372
RFYDAKVRYKRALLL

FKBP6

186

O75344
LLRYQRFEKAFLLAV

WDPCP

581

O95876
YLGKRNIIRKIAAAF

DOCK10

1381

Q96BY6
ELLFAALKALKYLFR

DOCK5

751

Q9H7D0
ALKALKYLFRFIIQS

DOCK5

756

Q9H7D0
NRIRFSKLLLKILFY

CLLU1

56

Q5K131
FAYFIRRRINKIQLI

GUCY2F

486

P51841
KLKQKGAIRRALFLY

ITGAV

531

P06756
LFIVFRKKVFRKNYS

FAT3

4171

Q8TDW7
RKLFRVYSNFLRGKL

EPO

166

P01588
FVNDIIARAKFYKRQ

LYG2

196

Q86SG7
FRIFAKKFDLLKYIQ

FMO2

91

Q99518
KRIYFRLRNKATGLF

CRYBG1

1586

Q9Y4K1
LAVYFIARKIRKKRL

CA14

306

Q9ULX7
LAFIVVKKRINTRFF

PIWIL3

756

Q7Z3Z3
LRLRKRFLNFFLEKY

MCOLN2

316

Q8IZK6
SVLNKFRIYLTLLRF

MCMBP

546

Q9BTE3
LDPILFYFTQKKFRR

P2RY6

296

Q15077
AFTKNIIKYDLRQRF

OLFML2A

481

Q68BL7
KRRKEYFLAVQILSL

PWWP3A

31

Q2TAK8
LFLATVLYIVKKRLF

BNIP1

211

Q12981
KKDAFLYQRTLQFIR

SERAC1

631

Q96JX3
NRFYKKAAAFVLRAV

SPAG6

96

O75602
IKVVQFFRILRIFKL

SLC9C1

711

Q4G0N8
FFLKRLQTIKEFFRL

SMG1

3021

Q96Q15
LFAAGAFILYKFKRK

SORCS2

1091

Q96PQ0
KQFRNKVLRVLVKIY

PSMD1

191

Q99460
LIFFLIVKARRKQAA

SIGLEC5

456

O15389
IFRSSNLRLKNFKVY

PKHD1

2406

P08F94
LIFIVLYKVGFFKRN

ITGAL

1106

P20701
VKRKIYEFIQQSFIR

SCN1A

1026

P35498
GRSRKDFKRYLLNFI

ABCD3

116

P28288
FIFIAALVRYKKLRN

PROKR1

81

Q8TCW9
YRVALAILKFFHKVR

TBC1D24

241

Q9ULP9
RFRYIILKQKFLEAL

WDR47

81

O94967
LFNVRYLNLKRSFTK

TLR3

321

O15455
KLVRKLIRLDNLFAY

VPS13A

201

Q96RL7
VFILFRKAVFQRLKL

PTGIR

291

P43119
EASRYIFLTKFRKFL

RNF123

521

Q5XPI4
LLYVREQGRRFKLKF

REXO5

331

Q96IC2
NFVFIAALTRYKKLR

PROKR2

71

Q8NFJ6
RIRGYVFKELKSFNL

TLR7

376

Q9NYK1
LKNIYRLFSADRKRV

PLCB1

171

Q9NQ66
YKRLFKAKNLIERFF

ZPBP

256

Q9BS86
KNLRLVKRLYFGLRV

TMEM81

166

Q6P7N7
LAQKLGFKIRKAYVR

ZC3H7A

166

Q8IWR0
LKVFYKFINLNRYKI

ZNF726

151

A6NNF4
LAVLLVFVRYRFNKS

ZBED5

286

Q49AG3
QFLFQTYLRTKKKLR

USP24

2171

Q9UPU5
KKFSVRYFLNLVLVD

VPS26A

266

O75436
VVAAFKQLYKRELLR

TIGD5

421

Q53EQ6
FVGLAVFVIYKFKRR

SORCS1

1111

Q8WY21
KVRQRAVALYFIDKL

TOP1

471

P11387
IGRYNDVFFRVLKKI

ZPBP2

156

Q6X784
IFARARNGKYRLLKI

TWF1

16

Q12792
YAFFKLLRDRLVLGK

TMEM39B

461

Q9GZU3